CA2822039C — Sulfur derivatives as chemokine receptor modulators
Assigned to Allergan Inc · Expires 2019-05-28 · 7y expired
What this patent protects
The present invention relates to sulfur derivatives of Formula l (see formula I) processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors including their use for treating ocular and skin inflam…
USPTO Abstract
The present invention relates to sulfur derivatives of Formula l (see formula I) processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors including their use for treating ocular and skin inflammatory diseases.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.